Aplenzin ER 348 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4FB1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,763
Award facts
- Contract value 100% obligated
- $11,762.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Aplenzin ER 348 mg tablets in quantities of 30-count units, with a contract ceiling value of $11,762.60 and a firm fixed-price structure. This non-set-aside award is scheduled for completion by December 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to fulfill this medication supply requirement supporting federal medical procurement needs. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a broad range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award reflects the contractor's continued role as a critical vendor within the DLA's Medical Supply Chain and aligns with the agency's strategic pharmaceutical procurement initiatives.
Quick answers
Who was awarded contract SPE2DR26F4FB1?
SPE2DR26F4FB1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F4FB1 worth?
The government has obligated $11,763 on SPE2DR26F4FB1.
Is contract SPE2DR26F4FB1 an order under another contract?
Yes. SPE2DR26F4FB1 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4FB1 competed?
The extent of competition for SPE2DR26F4FB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award